CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-17 | Mills Kenneth T. Director | Sale 10b5-1 | −2,210 | $13.77 | $30K | 408,035 |
| 2024-07-17 | Mills Kenneth T. Director | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,210 | 78,944 | ||
| 2024-07-16 | Mills Kenneth T. Director | Option exercise 10b5-1 | +200 | $3.76 | $752 | 408,235 |
| 2024-07-16 | Mills Kenneth T. Director | Sale 10b5-1 | −200 | $13.76 | $3K | 408,035 |
| 2024-07-16 | Mills Kenneth T. Director | Option exercise · Stock Options (Right to Buy) 10b5-1 | −200 | 81,154 | ||
| 2024-07-01 | Simpson Curran Chief Executive Officer | Grant or award | +56,458 | 179,785 | ||
| 2024-07-01 | Simpson Curran Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +272,189 | 272,189 | ||
| 2024-07-01 | KARABELAS ARGERIS N Director | Option exercise 10b5-1 | +10,000 | $3.76 | $38K | 21,286 |
| 2024-07-01 | KARABELAS ARGERIS N Director | Sale 10b5-1 | −10,000 | $11.27 | $113K | 11,286 |
| 2024-07-01 | KARABELAS ARGERIS N Director | Option exercise · Stock Options (Right to Buy) 10b5-1 | −10,000 | 30,000 | ||
| 2024-06-28 | Danos Olivier Chief Scientific Officer | Grant or award | +1,363 | $9.95 | $14K | 126,216 |
| 2024-05-31 | Zachary Jennifer Director | Grant or award | +4,790 | 14,296 | ||
| 2024-05-31 | Zachary Jennifer Director | Grant or award · Stock Options (Right to Buy) | +24,454 | 24,454 | ||
| 2024-05-31 | MIGAUSKY GEORGE V Director | Grant or award | +4,790 | 11,286 | ||
| 2024-05-31 | MIGAUSKY GEORGE V Director | Grant or award · Stock Options (Right to Buy) | +24,454 | 24,454 | ||
| 2024-05-31 | KARABELAS ARGERIS N Director | Grant or award | +4,790 | 11,286 | ||
| 2024-05-31 | KARABELAS ARGERIS N Director | Grant or award · Stock Options (Right to Buy) | +24,454 | 24,454 | ||
| 2024-05-31 | Glucksmann Alexandra Director | Grant or award | +4,790 | 11,286 | ||
| 2024-05-31 | Glucksmann Alexandra Director | Grant or award · Stock Options (Right to Buy) | +24,454 | 24,454 | ||
| 2024-05-31 | Bennett Jean Director | Grant or award | +4,790 | 11,286 |
Page 8 of 11 · 216 trades